glp 1 drugs hypothyroidism GLP-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response No Increased Risk for Thyroid

Individuals treated with GLP-1 medications exhibited a 7% reduction in risk for obesity-related cancer and an 8% reduction in all-cause mortality, results of a target trial emulation study showed

As GLP-1RAs become more commonly used, clinicians need to monitor for AV dermatological side effects while planning suitable treatment approaches for patients who develop this condition

PMID: 13 SchneiterPTappyL

In recent years, data have been accumulated suggesting effects of GLP-1 RAs on surrogate HF outcomes in HF patients across LVEF, including cardiac structure and function, exercise capacity and quality of life

Diarrhoea The frequency of diarrhoea also varies among trials, usually ranging between 5 and 25% (Table 1)

M., Du, Y., Lou, J., Gurbuz, S.,